The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Machatha Stephen since 2024.
This trader's CIK number is 1836354.
At the time of last reporting, Machatha Stephen was the Chief Development Officer of Aldeyra Therapeutics, Inc.. (stock ticker symbol ALDX).
Also see all insider trading activities at Aldeyra Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALDX | 0 | $0 | 22,073 | $113,720 | 0 | $0 |
| 2024 | ALDX | 0 | $0 | 45,809 | $174,567 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-11 | ALDX | Sale | 22,073 | 5.15 | 113,720 |
| 2024-08-12 | ALDX | Sale | 16,041 | 4.74 | 75,970 |
| 2024-03-12 | ALDX | Sale | 11,537 | 3.16 | 36,503 |
| 2024-03-11 | ALDX | Sale | 18,231 | 3.41 | 62,094 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Machatha Stephen (Chief Development Officer of Aldeyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.